# A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

> **NCT00047736** · PHASE3 · COMPLETED · sponsor: **Genentech, Inc.**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Tarceva (erlotinib HCl)

## Key facts

- **NCT ID:** NCT00047736
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047736, "A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00047736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*